Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer

NCT01995942 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.

NCT NCT01995942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01995942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer
Lead sponsor
Royal Marsden NHS Foundation Trust
Phase
Observational
Overall status
Unknown status
Start date
June 7, 2013
Completion date
February 2, 2022
Enrollment
246 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, adenocarcinoma, mucinous, carcinoma, colorectal neoplasms, digestive system diseases, digestive system neoplasms, gastrointestinal diseases, gastrointestinal neoplasms, intestinal diseases, intestinal neoplasms, neoplasms, neoplasms by histologic type, neoplasms by site, neoplasms, cystic, mucinous, and serous, neoplasms, glandular and epithelial, rectal diseases